Niti Aayog meets Top pharma execs to find ways to mitigate coronavirus impact; DoP seeks export ban on 12 APIs Medical Dialogues Bureau21 Feb 2020 6:28 AM GMTThe meeting was attended by Biocon's Kiran Mazumdar Shaw, Zydus' Pankaj Patel and Dr Reddy's Laboratories' Satish Reddy and other top pharma execs
MSD India appoints Rehan A Khan as Managing Director Medical Dialogues Bureau10 Jan 2020 6:34 AM GMTRehan A Khan was also a board member and advisor to several impacts led Private Equity funds and to healthcare companies in Africa, India, and...
More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs Medical Dialogues Bureau2 Jan 2020 9:18 AM GMTNew Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis Medical Dialogues Bureau24 Dec 2019 4:15 AM GMTSales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
Zydus Cadila unveils affordable anti-diabetic drug Vildagliptin under brands Vinglyn, Vinglyn M Medical Dialogues Bureau12 Dec 2019 6:23 AM GMTAhmedabad: With the Novartis Blockbuster Vildagliptin going off patent, Zydus Cadila has taken made its move towards affordable diabetes care in India...
Omega Healthcare appoints Sumit Sachdeva as Chief Growth Officer to expand pharma segment Medical Dialogues Bureau28 Nov 2019 3:40 AM GMTSumit Sachdeva brings over 20 years of experience in the Healthcare Services industry having held global positions strategizing and driving growth...
Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions Farhat Nasim20 Nov 2019 7:14 AM GMTNew Delhi: Pfizer Inc. recently announced the United States (U.S.) Food and Drug Administration (USFDA) has approved ABRILADA (adalimumab-afzb), as a...
Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris Medical Dialogues Bureau16 Nov 2019 3:50 AM GMTNew Delhi: Mylan N.V. and Pfizer Inc. recently announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn,...
Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore Medical Dialogues Bureau14 Nov 2019 4:00 AM GMTManaging director of Aurobindo Pharma N Govindarajan said We had another quarter of healthy performance where we continued to grow in the US and...
Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US Medical Dialogues Bureau13 Nov 2019 4:03 AM GMT"The decline in revenues and profits compared to the same period last year is primarily due to the anticipated drop in oseltamivir product sales in...
RedHill Biopharma Talicia wins USFDA nod for treating bacterial infection Medical Dialogues Bureau11 Nov 2019 3:45 AM GMTThe drug, Talicia, is an oral capsule comprising two antibiotics, amoxicillin and rifabutin, as well as omeprazole, a common treatment for...
Laurus Labs gets 2 USFDA observations for Visakhapatnam facility Farhat Nasim10 Nov 2019 4:30 AM GMTNew Delhi: Drug firm, Laurus Labs Ltd. recently said in a filing that the US health regulator has issued two observations after the inspection of its...